Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

CytoSorbents Stock News

CTSONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$1.23

0.054.24%

At close: -

$1.23

0.000.00%

After Hours: Jun 27, 4:01 PM EDT

CytoSorbents (CTSO) Forecast

News

Earnings CytoSorbents (CTSO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest CytoSorbents Stock News | NASDAQ:CTSO | Benzinga

Get the latest news on CytoSorbents stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on CytoSorbents performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, June 25, 2025

Deep Dive Into CytoSorbents Stock: Analyst Perspectives (6 Ratings)
Benzinga Insights
D. Boral Capital Maintains Buy on CytoSorbent...
Benzinga Newsdesk

Tuesday, June 24, 2025

CytoSorbents Files Request For Supervisory Re...
Benzinga Newsdesk
CytoSorbents Initiates Formal Appeal To FDA O...
Benzinga Newsdesk

Thursday, May 22, 2025

CytoSorbents Presents Real-World Analysis At ...
Benzinga Newsdesk

Thursday, May 15, 2025

D. Boral Capital Maintains Buy on CytoSorbent...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Neutral on Cyt...
Benzinga Newsdesk

Wednesday, May 14, 2025

Earnings Scheduled For May 14, 2025
Benzinga Insights

Tuesday, May 13, 2025

CytoSorbents's Earnings: A Preview
Benzinga Insights

Friday, May 02, 2025

Demystifying CytoSorbents: Insights From 4 Analyst Reviews
Benzinga Insights
D. Boral Capital Maintains Buy on CytoSorbent...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights

Thursday, May 01, 2025

CytoSorbents Provides Regulatory Update For I...
Benzinga Newsdesk

Monday, April 21, 2025

CytoSorbents Received $1.7M In Cash Proceeds ...
Benzinga Newsdesk

Thursday, April 03, 2025

HC Wainwright & Co. Reiterates Neutral on Cyt...
Benzinga Newsdesk

Tuesday, April 01, 2025

The Analyst Verdict: CytoSorbents In The Eyes Of 4 Experts
Benzinga Insights
D. Boral Capital Maintains Buy on CytoSorbent...
Benzinga Newsdesk

Monday, March 31, 2025

CytoSorbents Q4 2024 Adj. EPS $(0.03) Beats $...
Benzinga Newsdesk
Earnings Scheduled For March 31, 2025
Benzinga Insights

Friday, March 28, 2025

Insights into CytoSorbents's Upcoming Earnings
Benzinga Insights

Friday, March 21, 2025

CytoSorbents Continues To Reiterate Prelimina...
Benzinga Newsdesk
CytoSorbents Reschedules Q4 2024 Earnings Cal...
Benzinga Newsdesk

Tuesday, March 04, 2025

CytoSorbents Delays Earnings Release To Allow...
Benzinga Newsdesk

Tuesday, February 25, 2025

D. Boral Capital Maintains Buy on CytoSorbent...
Benzinga Newsdesk
CytoSorbents Raises $1.6M With Exercise Of Pr...
Benzinga Newsdesk

Monday, January 13, 2025

Expert Outlook: CytoSorbents Through The Eyes Of 7 Analysts
Benzinga Insights
D. Boral Capital Maintains Buy on CytoSorbent...
Benzinga Newsdesk

Friday, January 03, 2025

Health Care Equipment Supplier CytoSorbents Shares Dip Despite Projected Revenue Growth
Lekha Gupta
D. Boral Capital Maintains Buy on CytoSorbent...
Benzinga Newsdesk
Cytosorbents Reports Q4 Preliminary Results: ...
Benzinga Newsdesk

Monday, December 09, 2024

CytoSorbents to Raise Funds Through Rights Of...
Benzinga Newsdesk

Tuesday, November 12, 2024

D. Boral Capital Maintains Buy on CytoSorbent...
Benzinga Newsdesk

Monday, November 11, 2024

HC Wainwright & Co. Reiterates Neutral on Cyt...
Benzinga Newsdesk

Friday, November 08, 2024

EF Hutton Maintains Buy on CytoSorbents, Main...
Benzinga Newsdesk

Thursday, November 07, 2024

CytoSorbents Q3 2024 GAAP EPS $(0.04) Beats $...
Benzinga Newsdesk

Monday, November 04, 2024

EF Hutton Maintains Buy on CytoSorbents, Main...
Benzinga Newsdesk
CytoSorbents Submits Health Canada Medical De...
Benzinga Newsdesk

Tuesday, October 22, 2024

Analyst Scoreboard: 5 Ratings For CytoSorbents
Benzinga Insights
Expert Outlook: CytoSorbents Through The Eyes Of 5 Analysts
Benzinga Insights
EF Hutton Maintains Buy on CytoSorbents, Main...
Benzinga Newsdesk
The FDA Has Accepted Cytosorbents' De Novo Me...
Benzinga Newsdesk

Tuesday, October 01, 2024

EF Hutton Maintains Buy on CytoSorbents, Main...
Benzinga Newsdesk
CytoSorbents shares are trading lower. The co...
Benzinga Newsdesk
CytoSorbents Has Submitted Its DrugSorb-ATR M...
Benzinga Newsdesk

Wednesday, August 14, 2024

EF Hutton Maintains Buy on CytoSorbents, Main...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Neutral on Cyt...
Benzinga Newsdesk

Tuesday, August 13, 2024

CytoSorbents Q2 2024 GAAP EPS $(0.08) Beats $...
Benzinga Newsdesk
CytoSorbents Appoints Peter J. Mariani As CFO...
Benzinga Newsdesk
CytoSorbents Q2 2024 GAAP EPS $(0.08) Beats $...
Benzinga Newsdesk

Monday, July 29, 2024

Cytosorbents shares are trading higher after ...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved